Sean P. Lear
Genentech · 12 works · 259 citations · h-index 7
Top works
- Quantitative Comparison of Conventional and t-SNE-guided Gating Analyses
- Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody
- BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism
- A comprehensive analysis framework for evaluating commercial single-cell RNA sequencing technologies
- New cytometry tools for immune monitoring during cancer immunotherapy
- Comparative Analysis of Commercial Single-Cell RNA Sequencing Technologies
- Early Pharmacodynamic Changes in T-Cell Activation, Proliferation, and Cytokine Production Confirm the Mode of Action of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
- P008 Pharmacokinetics and pharmacodynamics in cynomolgus monkeys of AMG 181, a fully human anti α4 β7 antibody for treating inflammatory bowel disease
- Biomarker Analysis of a Phase Ia/Ib Open-Label, Multicentre Study of Tiragolumab or Tiragolumab + Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)
- Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease
- Tu1877: EVALUATING THE PHARMACODYNAMIC (PD) EFFECTS OF VIXARELIMAB IN PATIENTS WITH ULCERATIVE COLITIS (UC): DESIGN AND RATIONALE FOR A PHASE 1C STUDY
- OA-50 Pharmacodynamic effects of tiragolumab, as monotherapy and in combos with daratumumab and atezolizumab in patients with R/R MM: biomarker results from a phase 1a/1b trial